Vaginal Misoprostol Before Intrauterine Contraceptive Device Insertion

the current study was conducted to assess efficacy of vaginal misoprostol before IUD insertion following previous insertion failure

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Contraception

Age range

20 year–44 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 3

Primary location

AinShams university maternity hospital

Cairo, Abbassya, 11566, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

One previous failed attempt of IUD insertion.

Exclusion criteria

Uterine fibroid distorting the cavity.
Anatomical uterine abnormality with distortion of the cavity
Current pelvic inflammatory disease or recently treated pelvic inflammatory disease (PID) in the last three months.
Current purulent cervicitis (chlamydia or gonorrhea).
Immediately after septic abortion.
Uterus size less than 6 cm and more than 9 cm.

Treatment and study plan

Misoprostol

Drug

vaginal misoprostol prior IUD insertion

Placebos

Drug

vaginal placebo tablet prior IUD insertion

Primary outcomes

the success rate for IUD insertion.

Time frame: four hours after misoprostol dose

the success of IUD insertion after previous attempt failure

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Vaginal Misoprostol Before Intrauterine Contraceptive Device Insertion Following Previous Insertion Failure

Important dates

Study start: 2015
Primary completion: 2016
Study completion: 2016
First posted: Dec 31, 2018
Registry last updated: Dec 31, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed